UP!

IBN $26.19

IBN target price
26.19
0
0

Q reports

Period Date Adjusted Actuals EPS GAAP EPS
Q1 2022 2022-07-23 0.00 0.00
Q4 2021 2022-04-23 0.00 0.00
Q3 2021 2022-01-22 0.25 0.25
Q2 2021 2021-10-23 0.23 0.23
Q1 2021 2021-07-24 0.00 0.00
Q4 2020 2021-04-25 0.19 0.19
Q3 2020 2021-01-30 0.00 0.00
Q2 2020 2020-10-31 0.00 0.00
Q1 2020 2020-07-25 0.13 0.13
Q4 2019 2020-05-09 0.05 0.03

Ratings

2016-06-16 Downgrade JPMorgan Chase & Co. Overweight to Neutral
2016-05-03 Downgrade Goldman Sachs Buy to Neutral
2016-05-03 Downgrade Goldman Sachs Group Inc. Buy to Neutral
2016-04-21 Upgrade Credit Suisse Neutral to Outperform
2016-04-21 Upgrade Credit Suisse Group AG Neutral to Outperform
2015-09-14 Upgrade Goldman Sachs Neutral to Buy
2015-08-26 Upgrade Standpoint Research Hold to Buy $12.00
2015-03-11 Initiated Coverage Societe Generale Buy
2015-01-13 Downgrade Goldman Sachs Buy to Neutral
2014-03-20 Downgrade Standpoint Research Buy to Hold
2014-01-29 Initiated Coverage Standpoint Research Accumulate
2013-12-12 Upgrade Jefferies Group Hold to Buy
2010-01-14 Upgrade Deutsche Bank Hold to Buy
2008-03-06 Upgrade HSBC Securities Underweight to Neutral
2008-01-16 Reiterated Jefferies & Co Buy $62 to $87
2007-05-31 Downgrade UBS Buy to Neutral
2016-06-16 Downgrade JPMorgan Chase & Co. Overweight to Neutral
2016-05-03 Downgrade Goldman Sachs Buy to Neutral
2016-05-03 Downgrade Goldman Sachs Group Inc. Buy to Neutral
2016-04-21 Upgrade Credit Suisse Neutral to Outperform
2016-04-21 Upgrade Credit Suisse Group AG Neutral to Outperform

There is presents forecasts of rating agencies and recommendations for investors about this ticker

Major Shareholders

Name Relationship Total Shares Holding stocks